PRRT2 and cancer: Classical PKCs are activated by oncogenic Kras or growth factors, leading to similar downstream signaling for control of cancer cell survival and metastasis.24 Among novel PKCs, whereas PKCε and PKCδ have been implicated in cancer development or progression, relatively little is known about PKCη and PKCθ.